Jerome Siegmeister
Child & Adolescent Psychiatry · Miami, FLNPI 1700248077
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,933 and has fallen 51.2% since, to $944 in 2023.
Across 138 payments — averaging $21.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$503
- AbbVie$487
- Johnson & Johnson$327
- Takeda Pharmaceuticals U.S.A., Inc.$284
- Indivior Inc.$281
- Teva Pharmaceuticals USA, Inc.$255
- plus $862 from 9 others
What the payments were for
- Food & beverage$2,999100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $503 |
| AbbVie | 33 | $487 |
| Johnson & Johnson | 12 | $327 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $284 |
| Indivior Inc. | 12 | $281 |
| Teva Pharmaceuticals USA, Inc. | 8 | $255 |
| Alkermes, Inc. | 11 | $224 |
| Corium, LLC | 7 | $145 |
| Lundbeck LLC | 6 | $120 |
| Axsome Therapeutics, Inc. | 4 | $110 |
| Neurocrine Biosciences, Inc. | 4 | $106 |
| Ironshore Pharmaceuticals Inc. | 3 | $77 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $47 |
| Bausch Health US, LLC | 1 | $21 |
| Orexo US, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUSTEDO$123
How this compares
$2,999 in reported general payments places this provider in the 75th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 16 | $395 |
| Alprazolam | 11 | $293 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 13 | $190 |
| Escitalopram Oxalate | 14 | $152 |
| Buspirone Hcl | 20 | $143 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Miami
- Sean HoranMiami$17K
- Americo PadillaMiami$11K
- Jose AlvarezMiami$6K
- Nicole RedondoMiami$4K
- Gilbert SmithMiami$4K
- Jonathan ParkerMiami$4K
- Janeris LoredoMiami$3K
- Mauricio RodriguezMiami$3K
- Yasin BezMiami$2K
- Craig KuninsGulfport$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.